Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25862,909,0.83 [0.71-0.97],0.0203654357766546
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25892,145,0.96 [0.66-1.41],0.8451657677902513
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27494,156,0.92 [0.63-1.33],0.6472109646045372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20559,504,0.66 [0.54-0.81],6.157607135690738e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27431,93,0.89 [0.55-1.42],0.6137382552299355
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26706,77,0.79 [0.47-1.34],0.3884133057322632
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28486,92,0.86 [0.54-1.38],0.5268597592088837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28506,64,0.78 [0.45-1.37],0.3920712947011731
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26141,46,0.65 [0.33-1.26],0.2028205912455719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27954,107,0.83 [0.54-1.29],0.4141798734676376
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27913,66,0.84 [0.48-1.47],0.539577666975525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28550,66,0.46 [0.27-0.79],0.0052380560096242
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28505,101,1.07 [0.68-1.70],0.7688947787863517
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28495,91,1.01 [0.62-1.64],0.9818775829663215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,28309,45,1.12 [0.57-2.21],0.7488434248804068
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27654,395,0.85 [0.67-1.07],0.1619047746368475
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27406,147,0.95 [0.65-1.38],0.779379967190577
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27513,254,0.78 [0.59-1.04],0.09247692658446
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24783,29,0.98 [0.42-2.28],0.9700421928497432
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24803,49,2.13 [1.10-4.15],0.0257988907063827
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24882,128,0.83 [0.56-1.25],0.3822072504126221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24887,133,0.86 [0.58-1.29],0.4692872414869868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13917,294,0.99 [0.74-1.31],0.9259664237520272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11159,28,1.17 [0.48-2.84],0.7331012629692736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24802,48,1.61 [0.83-3.13],0.1613551715056675
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26379,832,0.97 [0.83-1.15],0.7497162095927218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27464,201,0.89 [0.65-1.23],0.4820661810022019
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28122,78,1.32 [0.79-2.20],0.2934793314365786
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28619,73,0.73 [0.43-1.23],0.2407708719016683
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,28379,49,0.71 [0.38-1.33],0.2867482207286341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28627,39,0.50 [0.25-1.01],0.0532348551240028
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Stomach,28668,32,0.44 [0.21-0.93],0.030589692821389
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,28352,302,1.33 [1.02-1.73],0.037500871392527
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28597,118,1.40 [0.91-2.14],0.1233737497140043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28602,97,1.05 [0.66-1.68],0.8264259930346558
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28567,47,1.52 [0.77-2.99],0.2230797224766418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",28569,47,1.52 [0.77-2.99],0.2230299542304648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,28460,251,1.15 [0.85-1.54],0.3697736465355045
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28628,111,1.03 [0.66-1.60],0.9081114258625288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,28537,193,1.29 [0.93-1.81],0.1286593063561985
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of breast,15805,94,1.01 [0.62-1.66],0.9693236845582048
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,15432,703,1.14 [0.94-1.37],0.1753503308907412
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27626,202,0.93 [0.67-1.29],0.6742199391006745
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27509,360,1.12 [0.87-1.43],0.3724557093470962
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27509,360,1.12 [0.87-1.43],0.3724557093470962
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26269,367,0.86 [0.68-1.09],0.2199508512728231
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28184,80,0.91 [0.55-1.53],0.7275938332720762
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28397,107,0.96 [0.61-1.50],0.848567504047467
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,25143,719,0.57 [0.48-0.67],1.0501976787519848e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27324,448,1.60 [1.28-1.99],3.182072995053658e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26806,116,1.31 [0.85-2.02],0.2220413872557792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27891,56,0.55 [0.31-0.98],0.0437094630044594
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26791,101,1.43 [0.90-2.27],0.1305045411876315
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,27028,338,0.34 [0.27-0.44],2.5850541290451066e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27018,328,0.34 [0.27-0.43],2.3610366164294843e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26670,187,0.58 [0.40-0.84],0.0038083054812068
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26674,184,0.56 [0.39-0.81],0.0020959052754064
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24975,551,0.50 [0.41-0.61],6.531565567718095e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24499,75,0.58 [0.35-0.97],0.0392061578183511
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24930,506,0.50 [0.41-0.61],2.139023785177004e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24468,44,0.86 [0.43-1.73],0.6789147301551359
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24504,80,0.41 [0.25-0.65],0.0002181399544447
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,24879,784,0.74 [0.62-0.87],0.0003220878277565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24394,299,0.61 [0.47-0.79],0.0002100007593837
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28220,230,0.65 [0.49-0.87],0.0042877063122689
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28292,164,0.58 [0.41-0.82],0.0020098106247207
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26639,84,0.77 [0.47-1.26],0.3035614113382454
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28549,84,0.85 [0.53-1.39],0.5267466738159557
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",24179,84,0.77 [0.47-1.26],0.2919619604995286
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Alcohol dependence,26653,98,0.41 [0.26-0.64],8.155656722813244e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,26618,68,0.46 [0.28-0.77],0.0033274603408655
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24169,74,0.38 [0.23-0.64],0.0002443886340454
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24497,402,0.81 [0.64-1.02],0.0714845979160988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression,26896,349,0.82 [0.65-1.05],0.121223241500831
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Depression or dysthymia,24342,306,0.79 [0.60-1.02],0.0736180558265361
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24243,148,0.76 [0.52-1.11],0.1592660402282357
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Other anxiety disorders,27129,71,0.87 [0.51-1.48],0.6005267554830742
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,25491,1483,0.81 [0.71-0.91],0.0007252444800875
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23769,165,1.00 [0.69-1.44],0.9901209937067712
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28460,133,1.03 [0.69-1.54],0.8781647173720244
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27282,503,0.76 [0.62-0.93],0.0075907268600503
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,26951,172,0.70 [0.49-0.98],0.0400938423589098
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,26884,105,1.37 [0.87-2.16],0.174075177837253
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28289,95,1.39 [0.86-2.25],0.173267782255766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28164,41,0.38 [0.20-0.74],0.004275815401856
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,26956,177,0.62 [0.44-0.87],0.0062682991378833
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,28034,138,0.63 [0.43-0.92],0.0181374656289865
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27509,634,0.98 [0.81-1.18],0.8131746511326452
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",27017,142,0.64 [0.44-0.93],0.0201478786118403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27215,340,1.14 [0.89-1.47],0.3072197626115973
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28444,87,0.74 [0.45-1.19],0.2160539401109416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,28413,56,0.68 [0.37-1.24],0.2076344832568045
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,28226,127,0.79 [0.53-1.18],0.2514503850599171
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28188,315,0.92 [0.71-1.19],0.5118227825434066
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,28045,172,0.94 [0.67-1.34],0.7446773063092984
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27964,91,0.77 [0.48-1.24],0.2816586076584533
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27979,106,0.96 [0.61-1.50],0.8608827655202554
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27922,49,0.79 [0.41-1.52],0.4821728668595226
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26919,67,1.10 [0.63-1.90],0.7457286268257044
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27042,190,0.96 [0.69-1.34],0.8095199676290061
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28040,133,1.04 [0.70-1.54],0.8586967746357829
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28413,24,0.76 [0.30-1.93],0.5692431465997871
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1805,24,1.44 [0.59-3.52],0.4229022293038271
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26632,24,0.71 [0.28-1.79],0.4694906635861073
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28285,51,0.97 [0.52-1.82],0.918941827301366
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28263,29,0.78 [0.34-1.78],0.5589465872939687
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28187,96,1.41 [0.88-2.26],0.156736910954387
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28244,101,0.96 [0.61-1.51],0.8540373534838951
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28540,127,1.21 [0.80-1.81],0.3611257028189778
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,28128,91,0.75 [0.47-1.20],0.2340718417634515
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22426,2014,0.63 [0.57-0.71],2.0914119408059388e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28334,39,1.35 [0.65-2.81],0.4277946911599384
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23511,1335,0.59 [0.52-0.68],1.863236637319316e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,23536,1360,0.58 [0.50-0.66],5.6340384185170705e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22227,51,0.22 [0.12-0.38],9.49689777921596e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27118,581,0.54 [0.45-0.65],5.7849311746492616e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,26895,358,0.64 [0.50-0.81],0.0002174750905703
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27936,143,0.51 [0.36-0.74],0.000317196338198
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28061,268,0.43 [0.33-0.56],2.0743217765661919e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28557,61,0.45 [0.26-0.76],0.0030090724456341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26702,165,0.35 [0.25-0.48],1.7937956329566588e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26959,433,0.44 [0.36-0.55],4.169311149201493e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28139,84,0.72 [0.44-1.18],0.1986360930386622
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28128,182,0.78 [0.56-1.09],0.1467311899197833
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28118,63,1.11 [0.62-1.98],0.7212178536685436
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28119,64,1.09 [0.61-1.93],0.7685183339857339
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22237,61,1.06 [0.58-1.92],0.8509773831781191
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25958,47,1.04 [0.53-2.04],0.913728438813284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,25987,76,0.71 [0.42-1.21],0.2075915187065363
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19580,97,1.34 [0.83-2.16],0.2358737202983784
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19677,194,0.90 [0.64-1.27],0.557627785371988
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,25953,42,0.89 [0.44-1.81],0.752291871943168
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25974,63,0.62 [0.35-1.09],0.0962517069802881
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28147,122,0.56 [0.37-0.83],0.004180644607619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28118,117,0.62 [0.41-0.93],0.0205356112053814
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28152,87,0.52 [0.33-0.83],0.0062171915861268
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28199,76,0.62 [0.37-1.03],0.0661677825229797
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27915,53,0.48 [0.27-0.87],0.0147025990579492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27946,84,0.64 [0.40-1.04],0.0721681748594056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27401,120,0.82 [0.54-1.25],0.3513877451314627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27380,99,0.97 [0.61-1.54],0.8932261461511619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28497,94,0.93 [0.58-1.48],0.7495783776606765
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,27728,447,1.20 [0.96-1.49],0.1132785382849614
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,27911,56,1.18 [0.64-2.19],0.5885441138313972
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,24254,1990,0.82 [0.74-0.91],0.0003600447567615
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28441,142,0.87 [0.59-1.28],0.4687068431411492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27428,189,0.66 [0.48-0.92],0.0145279051374401
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27399,160,0.68 [0.48-0.98],0.0374192186901186
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28039,218,0.73 [0.54-0.99],0.0420253904427596
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28037,216,0.72 [0.53-0.98],0.0345432226568127
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27762,682,0.94 [0.79-1.12],0.4973961692348777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,27179,99,0.91 [0.57-1.44],0.6865379428935601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,27191,111,0.75 [0.49-1.16],0.1982416985848188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27521,441,0.93 [0.75-1.16],0.5216213450145425
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,27318,238,1.02 [0.75-1.37],0.914500987688964
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16505,50,1.35 [0.69-2.65],0.3753577533487415
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26230,898,0.87 [0.75-1.02],0.0903906974829718
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,27933,110,0.60 [0.40-0.92],0.0173878949520192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27933,110,0.60 [0.40-0.92],0.0173878949520192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27933,110,0.60 [0.40-0.92],0.0173878949520192
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26847,816,0.93 [0.79-1.10],0.3920799795382328
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Asthma,21938,816,0.85 [0.72-1.01],0.0628204826001951
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21790,816,0.85 [0.72-1.00],0.055359920462175
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21922,800,0.85 [0.72-1.01],0.063574725354731
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28472,57,0.21 [0.13-0.34],4.1732623062620246e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,27310,43,0.17 [0.10-0.29],3.233900105740829e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28535,43,0.18 [0.11-0.31],3.4287107001356404e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27303,36,0.15 [0.08-0.28],9.128634844242667e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,27279,78,1.05 [0.62-1.77],0.8602546990669098
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,27384,183,0.81 [0.58-1.13],0.2161921600363137
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27799,86,0.91 [0.56-1.49],0.7193143395894248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20277,5247,0.84 [0.78-0.91],6.5347666661629705e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",28041,503,0.92 [0.74-1.13],0.4057010742740272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28595,143,0.96 [0.65-1.42],0.8292134823147789
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,28601,133,0.85 [0.57-1.28],0.437842553206063
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,27663,125,0.87 [0.58-1.32],0.5223680568183113
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27646,108,1.08 [0.69-1.68],0.7385848841122535
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28580,159,0.94 [0.64-1.36],0.7250202093418177
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27633,95,0.77 [0.48-1.23],0.27732313760876
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27371,66,0.98 [0.56-1.72],0.9465304142353465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28540,46,1.00 [0.51-1.96],0.9976419118731812
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23058,207,0.65 [0.48-0.89],0.0078814983955283
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24622,1771,0.85 [0.76-0.96],0.006748427918859
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,23126,275,0.68 [0.51-0.89],0.005137236045792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23412,561,0.88 [0.72-1.07],0.2012831232253802
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22917,66,0.91 [0.52-1.60],0.7399345052959752
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22983,132,0.88 [0.59-1.31],0.516566401271445
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22883,32,0.74 [0.33-1.65],0.4609156479627202
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,22955,104,0.65 [0.42-1.01],0.05303661309543
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,22956,105,0.71 [0.46-1.10],0.1291469426555275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28562,74,0.73 [0.43-1.22],0.225994153699531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,22955,104,0.73 [0.47-1.13],0.1595890921886189
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23501,650,0.84 [0.70-1.01],0.0583594885614955
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,28473,165,1.36 [0.95-1.96],0.0949583316336241
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,23241,390,1.03 [0.81-1.30],0.8186144463552587
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22967,116,0.92 [0.60-1.41],0.6862993408152094
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28465,192,1.08 [0.77-1.50],0.6671461824850066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,28436,128,1.44 [0.95-2.17],0.0845032577256765
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,25835,1203,0.74 [0.65-0.85],1.166965190856154e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,25037,405,0.60 [0.48-0.75],5.97404375508457e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,24755,123,0.42 [0.28-0.62],1.108127123385614e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,24728,96,0.93 [0.59-1.48],0.7710535985209735
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25244,612,0.86 [0.72-1.04],0.1246997038873101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27760,760,0.84 [0.71-0.99],0.0389384795940343
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,23598,1705,0.90 [0.81-1.02],0.0905956993653115
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28326,75,0.51 [0.31-0.86],0.0106147585899348
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28582,106,0.46 [0.30-0.70],0.0003541078700382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,27106,106,0.46 [0.30-0.70],0.000312856624389
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27081,81,0.48 [0.29-0.78],0.0031346755229288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28528,133,0.43 [0.30-0.63],9.230306252574103e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,27133,133,0.43 [0.29-0.62],7.830780406343551e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27115,115,0.40 [0.27-0.60],7.718801019897623e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27604,604,0.97 [0.80-1.17],0.7345155837867299
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27599,599,0.98 [0.81-1.18],0.8103955356208661
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21965,72,0.87 [0.51-1.49],0.6130889823228411
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal stricture,28320,72,0.90 [0.53-1.54],0.7100489079281673
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21942,49,0.87 [0.45-1.67],0.6753852390127255
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22203,310,0.91 [0.70-1.19],0.4906696726800269
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22075,182,1.00 [0.71-1.41],0.9979867760778924
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22151,258,1.08 [0.81-1.45],0.5957599296794625
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,27461,231,1.09 [0.81-1.48],0.5588476113765137
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28235,84,1.14 [0.69-1.88],0.6215932552870906
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22074,181,1.06 [0.75-1.51],0.725577913791972
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21983,90,0.65 [0.40-1.05],0.0796068272095419
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22695,802,0.80 [0.68-0.95],0.0098553670583905
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,22079,186,0.61 [0.44-0.84],0.0029383912388199
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28222,71,1.43 [0.82-2.48],0.2041148685886666
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,27909,124,0.68 [0.46-1.01],0.0561292258986227
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,27850,65,0.84 [0.48-1.48],0.5519677619182944
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27393,539,0.90 [0.74-1.10],0.3244888074311912
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,27278,424,0.99 [0.79-1.25],0.958076545361242
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,26935,81,0.49 [0.30-0.79],0.0032549041978662
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26901,47,0.55 [0.29-1.05],0.0692639553513868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,26917,63,0.61 [0.35-1.06],0.078826730028966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28491,63,0.61 [0.35-1.05],0.0753722309568317
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27372,289,0.85 [0.65-1.11],0.2425134682123678
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27151,68,0.99 [0.57-1.74],0.9826440960206482
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,27136,53,0.96 [0.51-1.80],0.8973110524074517
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27125,42,1.00 [0.49-2.03],0.9960665029646478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27269,186,0.76 [0.54-1.05],0.0967804086159536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,27264,181,0.77 [0.55-1.07],0.1216360502623986
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25994,1520,0.84 [0.74-0.95],0.0052840543954847
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28273,103,0.85 [0.54-1.34],0.4847338745578338
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28222,477,0.73 [0.59-0.90],0.0033810056412422
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27533,544,1.00 [0.82-1.22],0.9922272317491864
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27859,402,0.79 [0.63-1.00],0.0476805571162428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27564,107,0.74 [0.48-1.14],0.1681547295044756
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27685,228,0.91 [0.67-1.23],0.5398046470594468
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28401,88,0.77 [0.48-1.25],0.2934995680085592
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28385,72,0.62 [0.37-1.04],0.0718858338486619
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28365,52,1.01 [0.54-1.89],0.9838413260221616
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28489,35,0.43 [0.21-0.89],0.0225358623741808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28486,32,0.46 [0.21-0.99],0.0484688331958832
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27809,64,0.37 [0.22-0.62],0.000166991032891
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28110,365,0.83 [0.65-1.05],0.1170466783969874
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,27062,73,1.23 [0.72-2.12],0.4458000162625888
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27091,102,1.33 [0.84-2.11],0.2173006810977565
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27075,86,1.20 [0.73-1.97],0.4775400007922138
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27205,216,0.89 [0.65-1.21],0.4487002540060476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27178,189,0.88 [0.63-1.22],0.4396686126342057
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22175,3591,0.96 [0.88-1.04],0.3055014682820345
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23827,1898,1.00 [0.89-1.12],0.9749489075764785
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26169,1134,1.03 [0.89-1.18],0.7151162391113738
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22048,119,0.77 [0.50-1.17],0.2131770828459938
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22274,345,0.77 [0.60-0.99],0.0438520665092087
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28321,113,0.75 [0.49-1.15],0.1928501839853803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28338,101,0.89 [0.57-1.40],0.6241026541945598
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22601,672,0.95 [0.80-1.14],0.611493954024037
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",25255,672,0.95 [0.79-1.14],0.5651042966835428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21975,46,1.06 [0.54-2.09],0.8679571494176176
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28264,45,1.14 [0.58-2.25],0.7056558149926688
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22084,155,0.90 [0.62-1.30],0.5727668984146664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21954,25,3.58 [1.48-8.64],0.0045963400178622
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22055,126,1.09 [0.72-1.64],0.6968930831029727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28550,61,1.25 [0.70-2.25],0.4550327101378031
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22263,334,0.86 [0.67-1.12],0.2649640962114942
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22160,231,0.96 [0.71-1.30],0.7921294149649899
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23193,1264,1.07 [0.94-1.23],0.3200697652173253
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21967,38,1.30 [0.61-2.78],0.4961752535439399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22106,177,1.83 [1.29-2.59],0.0007118019067375
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21964,35,1.72 [0.79-3.76],0.1755347074583112
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21960,31,1.68 [0.73-3.88],0.220236309757395
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22464,535,0.96 [0.78-1.17],0.6698437085225153
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22374,445,0.94 [0.75-1.17],0.5757106826788124
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22693,287,1.04 [0.79-1.36],0.7970801759821448
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28258,152,0.69 [0.48-1.00],0.0527698781538155
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28147,41,0.37 [0.19-0.72],0.0032606866656963
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25627,49,1.62 [0.84-3.11],0.1484552240242645
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25801,223,0.63 [0.47-0.85],0.0027734835775001
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26503,925,0.92 [0.79-1.08],0.3040965697510812
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25717,139,0.80 [0.54-1.17],0.2542184696886089
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25635,57,0.43 [0.24-0.76],0.0038383007962148
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26357,779,0.92 [0.78-1.08],0.3058011218543893
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25637,59,1.10 [0.60-2.01],0.7542412395924574
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25837,259,0.83 [0.63-1.11],0.2054896576770128
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25695,117,0.56 [0.37-0.85],0.0066424212397531
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25652,74,1.32 [0.77-2.27],0.3088080668530243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25730,152,1.36 [0.94-1.98],0.1057577156711478
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25646,68,1.55 [0.89-2.70],0.1257080838107265
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25909,331,0.92 [0.72-1.19],0.544002235888601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25328,293,1.01 [0.77-1.33],0.9385709623867734
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25091,56,0.64 [0.35-1.16],0.1396160764348033
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25091,56,1.61 [0.87-2.98],0.1316094195057647
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25154,119,1.10 [0.72-1.68],0.6687695803934729
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25093,58,0.40 [0.22-0.70],0.0013662615600259
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25101,66,0.84 [0.48-1.46],0.5307710448987363
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25085,50,0.75 [0.40-1.42],0.3835215063184551
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25270,235,1.18 [0.87-1.60],0.2759688711820566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25088,53,1.18 [0.63-2.22],0.6108354809732426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25091,56,0.96 [0.52-1.76],0.8884970299920958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25149,114,1.18 [0.76-1.82],0.4567300893072773
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25109,74,1.38 [0.80-2.36],0.2444392858402585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25475,440,1.04 [0.84-1.30],0.6986837877351479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25183,148,1.07 [0.73-1.57],0.7124755352405051
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25262,227,1.20 [0.88-1.63],0.2436607638944159
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27250,102,0.94 [0.60-1.46],0.7732875423710943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27495,347,1.04 [0.81-1.34],0.7380508903254966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27206,58,0.58 [0.32-1.04],0.065360258907789
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27217,69,1.72 [0.98-3.00],0.056597541806401
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27266,118,1.38 [0.90-2.11],0.1424097342212603
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24235,4498,1.15 [1.07-1.24],0.0003274954322682
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11644,421,0.85 [0.67-1.07],0.1755670414967091
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27090,212,0.56 [0.41-0.76],0.0002124714322167
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26934,56,0.70 [0.38-1.28],0.2486762607315269
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27247,44,0.69 [0.35-1.35],0.2791073253861602
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27253,50,0.27 [0.15-0.46],2.849355474486727e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27256,53,0.45 [0.25-0.81],0.0078867220634421
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28279,250,0.74 [0.56-0.99],0.042637302847089
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28352,53,0.69 [0.37-1.26],0.2265805679548126
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28202,173,0.81 [0.57-1.15],0.2331446600333364
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28128,99,0.78 [0.49-1.23],0.2892091083974643
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27107,898,0.97 [0.83-1.13],0.6596358284091755
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,26293,84,0.96 [0.58-1.58],0.87050199562388
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26275,66,0.91 [0.52-1.59],0.7294602156740737
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26396,187,0.64 [0.46-0.89],0.0076668341068567
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26297,88,0.79 [0.48-1.29],0.3419509971334753
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26840,631,1.11 [0.92-1.33],0.2822569734894457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11297,74,0.73 [0.43-1.26],0.2583492146991275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11259,36,0.84 [0.38-1.86],0.6706409214993561
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydrocele,11262,39,0.56 [0.27-1.19],0.1301084808085267
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11316,93,0.71 [0.44-1.17],0.178969233482288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11290,67,1.00 [0.56-1.77],0.9872511539099776
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11327,104,1.04 [0.66-1.64],0.8758444178056743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15651,254,1.36 [1.01-1.84],0.0458612485010539
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15470,73,1.17 [0.67-2.05],0.5753669668858861
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15487,90,1.37 [0.82-2.28],0.227872529174268
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15452,55,1.45 [0.76-2.77],0.2627258716270505
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15615,399,0.96 [0.75-1.22],0.7297579425673082
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15300,84,0.96 [0.57-1.63],0.8936904687119566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15411,195,0.89 [0.63-1.25],0.5018962186923958
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14399,2833,0.90 [0.81-0.99],0.0385339460565773
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,11870,304,1.08 [0.82-1.43],0.5891018406970152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11659,93,1.44 [0.87-2.38],0.1553212603998016
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11685,119,0.72 [0.47-1.11],0.1326103345405281
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11879,313,0.82 [0.62-1.07],0.1411138563453312
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11876,310,0.91 [0.69-1.20],0.5137304745362476
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,12054,488,0.86 [0.69-1.07],0.1794730717017663
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11737,171,1.10 [0.76-1.59],0.6019261052521601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11790,224,0.62 [0.46-0.85],0.002532260490563
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11650,84,1.05 [0.62-1.78],0.8545457471454767
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11710,144,0.61 [0.41-0.90],0.0118673510371363
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15805,207,0.77 [0.56-1.07],0.1175626347584505
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15815,198,0.79 [0.56-1.10],0.1590886107954831
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15835,113,0.84 [0.54-1.31],0.4426763824397628
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15826,123,0.82 [0.54-1.25],0.3589404212000394
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11640,74,0.70 [0.41-1.20],0.1949712878365066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11628,62,0.81 [0.44-1.48],0.4936666738021473
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11643,77,0.83 [0.48-1.44],0.5153316544644704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,15727,387,0.83 [0.65-1.06],0.1273279331818321
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12735,1169,0.88 [0.76-1.02],0.087629797430099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12365,799,0.92 [0.77-1.09],0.3169280172993772
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15813,160,0.65 [0.45-0.93],0.0181023471967187
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11928,362,0.85 [0.66-1.10],0.2189316509387661
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11853,287,1.05 [0.79-1.39],0.7574258568360469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11834,268,0.99 [0.74-1.33],0.9564029500541996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female infertility,11681,115,1.14 [0.71-1.81],0.583941559837875
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11674,108,1.09 [0.67-1.76],0.7226105055833727
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15828,888,1.35 [1.13-1.62],0.0009975630143305
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15832,1214,1.21 [1.03-1.42],0.0193265718641357
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15830,486,0.99 [0.79-1.24],0.953417970660688
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15482,138,1.15 [0.76-1.74],0.5101082544244003
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15538,194,0.94 [0.67-1.34],0.7421927481672237
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15514,170,1.02 [0.71-1.48],0.8966828415879577
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15847,167,1.19 [0.81-1.75],0.3695704052011255
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15849,164,1.23 [0.83-1.80],0.3021520045297128
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15847,422,1.02 [0.80-1.30],0.8771932416365599
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15551,126,0.86 [0.56-1.33],0.4970739365466305
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15658,233,1.25 [0.91-1.73],0.1718960575549956
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,15089,149,1.69 [1.12-2.55],0.0127064729124117
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,15143,203,1.24 [0.87-1.76],0.2274605920653544
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,15193,253,0.97 [0.71-1.33],0.8543569497417876
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,15088,148,1.32 [0.87-1.99],0.1859926513651412
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,15080,140,1.52 [1.00-2.31],0.0488867062624272
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,15093,153,1.55 [1.03-2.31],0.0344994568519079
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14853,235,1.51 [1.08-2.11],0.0160864276601727
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],15062,444,1.24 [0.97-1.58],0.0847987740787228
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15297,679,1.24 [1.00-1.52],0.0451483304428697
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15851,173,0.91 [0.63-1.32],0.6124414688444807
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14377,132,1.25 [0.81-1.92],0.3145462202580436
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14721,103,1.43 [0.87-2.34],0.1568704467492363
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15859,346,1.07 [0.82-1.40],0.6144891154622513
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15777,264,1.04 [0.77-1.41],0.8021819290433239
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15845,257,1.03 [0.76-1.40],0.8553924247546167
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15835,247,1.05 [0.77-1.44],0.7661483356036826
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28410,37,1.60 [0.75-3.39],0.2226720526008898
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26978,541,0.78 [0.64-0.95],0.0141949628859766
